Get the Stockscreener App
0.9701
2.99%
-0.0299
Clearmind Medicine Inc stock is traded at $0.9701, with a volume of 40,236.
It is down -2.99% in the last 24 hours and up +11.25% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$1.00
Open:
$0.98
24h Volume:
40,236
Relative Volume:
0.05
Market Cap:
$4.14M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0227
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
-5.82%
1M Performance:
+11.25%
6M Performance:
-29.70%
1Y Performance:
-35.33%
1-Day Range:
$0.9505
$0.98
1-Week Range:
$0.9505
$1.04
52-Week Range:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.9701 | 5.38M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Stock (CMND) Latest News
How Clearmind Medicine Inc. stock performs during market volatilityFree Daily Volume Spike Trading Signals - Newser
What are the technical indicators suggesting about Clearmind Medicine Inc.Stock Strategy Recommendation From AI Tools - jammulinksnews.com
Can volume confirm reversal in Clearmind Medicine Inc.Safe Investment Ideas with Growth Upside - Newser
What makes Clearmind Medicine Inc. stock price move sharplyStock Market Entry Points To Watch Now - jammulinksnews.com
What are Clearmind Medicine Inc. company’s key revenue driversReal Time Outlook With High Returns - jammulinksnews.com
Will Clearmind Medicine Inc. benefit from macro trends7-Day Equity Return Range Forecast Model - Newser
Analyzing net buyer seller activity in Clearmind Medicine Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Published on: 2025-07-31 19:52:46 - Newser
Does Clearmind Medicine Inc. show high probability of reboundRSI Divergence and Support Breakout Analysis - Newser
What is Clearmind Medicine Inc. company’s growth strategyValue Investing Opportunities For 2025 - jammulinksnews.com
How Clearmind Medicine Inc. stock reacts to Fed policy changesStock Trading Session Highlights and Summary - Newser
SciSparc-Clearmind Collaboration Leads to Filing of - GlobeNewswire
Clearmind files patent for obesity and liver disease treatment By Investing.com - Investing.com South Africa
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease - The Manila Times
Breakthrough Patent: New Drug Combination Targets 890M Obesity Patients and Fatty Liver Disease - Stock Titan
Moving Average Trends for Clearmind Medicine Inc. Stock: What They IndicateFree Low Risk Picks for Daily Trading - Newser
Will Clearmind Medicine Inc. Benefit From Broader Market BounceIntraday Trend Analysis for Fast Gains Released - beatles.ru
Trendlines Converge — Decision Point for Clearmind Medicine Inc.Early Entry Picks Before News Breakout Reviewed - metal.it
Published on: 2025-07-28 23:40:33 - metal.it
Clearmind Medicine Inc. Rebounds From Oversold Zone — Now WhatReal Profit Trade Plan Suggestions Shared Widely - metal.it
Clearmind Medicine Inc. Stock Support and Resistance Levels You Should KnowSwing Watchlist With Tight Stop Placement - Newser
How strong is Clearmind Medicine Inc. company’s balance sheetBuild wealth steadily with smart trading - jammulinksnews.com
What are analysts’ price targets for Clearmind Medicine Inc. in the next 12 monthsHarness the power of proven investment plans - jammulinksnews.com
Is it the right time to buy Clearmind Medicine Inc. stockMaximize your portfolio’s earning power - jammulinksnews.com
How many analysts rate Clearmind Medicine Inc. as a “Buy”Build wealth steadily with smart trading - jammulinksnews.com
Clearmind Medicine Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming2x Return Forecast - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionFree Short-Term Stock Picks - Newser
Top Risks to Consider Before Buying Clearmind Medicine Inc. StockFree Stock Investment Discussion Area - Newser
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):